Chitogenx Stock Today
| CHNXF Stock | USD 0.01 0.0001 1.96% |
Performance0 of 100
| Odds Of DistressOver 88
|
ChitogenX is trading at 0.005 as of the 22nd of November 2024. This is a 1.96% down since the beginning of the trading day. The stock's lowest day price was 0.005. ChitogenX has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for ChitogenX are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of November 2023 and ending today, the 22nd of November 2024. Click here to learn more.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada. The company has 51.04 M outstanding shares. More on ChitogenX
Moving together with ChitogenX OTC Stock
| 0.79 | NVO | Novo Nordisk AS | PairCorr |
| 0.78 | NONOF | Novo Nordisk AS | PairCorr |
| 0.75 | CSLLY | CSL | PairCorr |
| 0.69 | CMXHF | CSL Limited | PairCorr |
| 0.85 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against ChitogenX OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ChitogenX OTC Stock Highlights
| Pres CEO | Philippe Deschamps |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
ChitogenX [CHNXF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ChitogenX's market, we take the total number of its shares issued and multiply it by ChitogenX's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ChitogenX classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 51.04 M outstanding shares.
ChitogenX has accumulated about 2.19 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check ChitogenX Probability Of Bankruptcy
Ownership AllocationChitogenX holds a total of 51.04 Million outstanding shares. ChitogenX shows 17.44 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ChitogenX Ownership Details
ChitogenX Risk Profiles
| Mean Deviation | 3.22 | |||
| Standard Deviation | 10.94 | |||
| Variance | 119.65 | |||
| Risk Adjusted Performance | (0.04) |
ChitogenX Stock Against Markets
Picking the right benchmark for ChitogenX otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ChitogenX otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ChitogenX is critical whether you are bullish or bearish towards ChitogenX at a given time. Please also check how ChitogenX's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in ChitogenX without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
ChitogenX Corporate Executives
Elected by the shareholders, the ChitogenX's board of directors comprises two types of representatives: ChitogenX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ChitogenX. The board's role is to monitor ChitogenX's management team and ensure that shareholders' interests are well served. ChitogenX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ChitogenX's outside directors are responsible for providing unbiased perspectives on the board's policies.
Other Information on Investing in ChitogenX OTC Stock
ChitogenX financial ratios help investors to determine whether ChitogenX OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ChitogenX with respect to the benefits of owning ChitogenX security.